BioChemInsights & Becker & Associates will exhibit at the Spring 2000 CDMA Meeting

"Capturing Growth through Innovation in 2000 & Beyond" 

February 15, 2000   -  Malvern, Pa USA

    The Commercial Development & Marketing Association (CDMA) is the world's leading professional association dedicated to fostering, promoting & sharing business processes for long term growth & value creation in the chemical & allied industries. The spring meeting will focus on growth & innovation as we enter the next millennium. Visit the CDMA's website at www.cdmaonline.org. 

    BioChemInsights will be available to demonstrate the Becker Databases on Monday, March 13th during the annual CDMA Conference at the Sheraton Society Hill in  Philadelphia.  Please feel free to contact us to if you will be able to visit us at the show.

    Becker & Associates is a company specializing in the analysis & development of pharmaceuticals, pesticides & fine chemical production.  Founded in Paris in 1994, its main activities include research & development, chemical technology & market studies, & publication of leading-edge databases for Life Science Molecules.

    BioChemInsights offers advisory services to "Manage Knowledge for Strategic Business Decisions" by providing leading edge tools for information systems & data mining.  BCI works with its clients to analyze & understand industry trends in pharmaceuticals drug development linked to fine chemicals & biotechnology.  The company provides high-level strategic planning for business growth related to leveraging technology or identifying, analyzing & pursuing acquisition opportunities. Its due diligence activities draw upon its expertise & insights in understanding & valuing the interactions between chemistry & biology in drug development & drug candidate screening from bioprocessing & metabolic engineering to combinatorial chemistry, high-throughput screening, proteomics, & bioinformatics.

    BCI offers its clients an unequalled breadth & depth of experience to help them expand their knowledge capital & discover new paths to sustained performance in life science businesses.